Urine test for bladder cancer to be developed by University of Birmingham and Nonacus

BHP founder-member the University of Birmingham and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have partnered to develop a non-invasive test for bladder cancer. The test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus, and a panel of biomarkers … Continue reading “Urine test for bladder cancer to be developed by University of Birmingham and Nonacus”